These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10988002)

  • 1. C-reactive protein and dangerous liaisons.
    Biasucci LM
    Eur Heart J; 2000 Oct; 21(19):1560-2. PubMed ID: 10988002
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possible association between serum C-reactive protein concentrations and ischemic heart disease].
    Shapira I; Zeltzer D; Berliner S
    Harefuah; 1999 Aug; 137(3-4):149-53. PubMed ID: 10959309
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetically elevated C-reactive protein and vascular disease.
    Morita H; Nagai R
    N Engl J Med; 2009 Feb; 360(9):934; author reply 934-5. PubMed ID: 19256031
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy.
    Chirinos JA; Zambrano JP; Chakko S; Schob A; Veerani A; Perez GO; Mendez AJ
    Am J Cardiol; 2005 Jan; 95(1):88-90. PubMed ID: 15619397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes.
    O'Malley T; Ludlam CA; Riemermsa RA; Fox KA
    Eur Heart J; 2001 Jul; 22(14):1226-34. PubMed ID: 11440495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically elevated C-reactive protein and vascular disease.
    Bubb MR
    N Engl J Med; 2009 Feb; 360(9):933-4; author reply 934-5. PubMed ID: 19256030
    [No Abstract]   [Full Text] [Related]  

  • 7. [C-reactive protein and risk of ischaemic vascular and cerebrovascular disease--secondary publication].
    Zacho J; Tybjaerg-Hansen A; Jensen JS; Grande P; Sillesen H; Nordestgaard BG
    Ugeskr Laeger; 2009 May; 171(21):1751-5. PubMed ID: 19492468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The level of C-reactive protein and major artery elasticity in patients with ischemic heart disease].
    Iliukhin OV; Iliukhina MV; Kalganova EL; Lopatin IuM
    Ter Arkh; 2007; 79(1):56-8. PubMed ID: 17385467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory markers of ischemic coronary syndromes.
    Manzoli A; Patti G; Di Sciascio G
    Ital Heart J; 2001 Sep; 2 Suppl 3():29S-30S. PubMed ID: 11593927
    [No Abstract]   [Full Text] [Related]  

  • 10. C-reactive protein in healthy and in sick populations.
    Danesh J; Pepys MB
    Eur Heart J; 2000 Oct; 21(19):1564-5. PubMed ID: 10988004
    [No Abstract]   [Full Text] [Related]  

  • 11. C-reactive protein, genetically elevated levels and risk of ischemic heart and cerebrovascular disease.
    Zacho J; Tybjaerg-Hansen A; Nordestgaard BG
    Scand J Clin Lab Invest; 2009; 69(4):442-6. PubMed ID: 19533498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein--should it be used to assess cardiac risk?
    Sitzman K
    AAOHN J; 2005 Apr; 53(4):188. PubMed ID: 15853295
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of endothelin-1 with transient myocardial ischemia in patients with unstable angina pectoris.
    Lanza GA; Bencardino G; Sestito A; Shaw S; Sgueglia GA; Infusino F; Lüscher TF; Crea F
    Am J Cardiol; 2005 Feb; 95(4):492-4. PubMed ID: 15695136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C reactive protein and acute phase of ischaemic stroke.
    Di Napoli M
    BMJ; 2001 Jun; 322(7302):1605-6. PubMed ID: 11458909
    [No Abstract]   [Full Text] [Related]  

  • 15. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
    Canale ML; Stroppa S; Caravelli P; Petronio AS; Mariotti R; Mariani M; Balbarini A; Barsotti A
    Coron Artery Dis; 2006 Dec; 17(8):693-8. PubMed ID: 17119378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C-reactive protein in coronary disease--pathogenic factor or marker of the disease].
    Goch JH; Sadurska J
    Pol Merkur Lekarski; 2002 Jul; 13(73):70-3. PubMed ID: 12362513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with C-reactive protein at the early stage of acute myocardial infarction in men.
    García González MJ
    Cardiol J; 2009; 16(4):388; author reply 389. PubMed ID: 19653189
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inflammatory and anti-inflammatory markers in acute coronary syndromes. Ready for use in the clinical setting?].
    García-Moll X
    Rev Esp Cardiol; 2005 Jun; 58(6):615-7. PubMed ID: 15970115
    [No Abstract]   [Full Text] [Related]  

  • 19. Variability of high-sensitivity C-reactive protein in chronic heart failure.
    Araújo JP; Friões F; Azevedo A; Lourenço P; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Cardiology; 2009; 113(3):180-3. PubMed ID: 19136826
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
    Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
    Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.